logo

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

Signature Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 24

% Expired Patents = 12.5



Forward Citations = 259

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Thomas E Jenkins (24 out of 61 patents)

silverMedal Craig Husfeld (13 out of 85 patents)

bronzeMedal Julie D Seroogy (9 out of 9 patents)

4.  Jonathan W Wray (9 out of 25 patents)

5.  Aleksandr Kolesnikov (2 out of 37 patents)

6.  Craig O Husfeld (0 patent)

7.  Craig O Husfeld (0 patent)


24 patents:

1. 11400062 - Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof (2022-08-02),
2. 11179355 - Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof (2021-11-23),
3. 10028945 - Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof (2018-07-24),
4. 9585963 - Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof (2017-03-07),
5. 9534014 - Pharmaceutical compositions with attenuated release of phenolic opioids (2017-01-03),
6. 9499581 - Compositions comprising enzyme-cleavable oxycodone prodrug (2016-11-22),
7. 9493477 - Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof (2016-11-15),
8. 9238020 - Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug (2016-01-19),
9. 9139612 - Active agent prodrugs with heterocyclic linkers (2015-09-22),
10. 9095627 - Opioid prodrugs with heterocyclic linkers (2015-08-04),
11. 9040032 - Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof (2015-05-26),
12. 9023860 - Pro-drugs for controlled release of biologically active compounds (2015-05-05),
13. 8962547 - Compositions comprising enzyme-cleavable oxycodone prodrug (2015-02-24),
14. 8921418 - Controlled release of phenolic opioids (2014-12-30),
15. 8871815 - Therapeutic compounds (2014-10-28),
Company Overview
Signature Therapeutics, Inc. is a biotechnology company based in Palo Alto, California, focused on advancing innovative therapeutic solutions. The organization specializes in the development of novel drug candidates aimed at addressing unmet medical needs across various disease areas. With a strong emphasis on research and development, Signature Therapeutics leverages cutting-edge technologies to enhance drug efficacy and safety, positioning itself at the forefront of biopharmaceutical innovation.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

24 Patents

#73 in Palo Alto, CA

#3,294 in California

#13,906 in US

#26,716 in the World

Palo Alto, CA (US)
Palo Alto, CA, United States of America

Signature Therapeutics, Inc.

Forward Citations = 259

5 inventors:

goldMedal Thomas E Jenkins (24 out of 61 patents)

silverMedal Craig Husfeld (13 out of 85 patents)

bronzeMedal Julie D Seroogy (9 out of 9 patents)

4.  Jonathan W Wray (9 out of 25 patents)

5.  Aleksandr Kolesnikov (2 out of 37 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Signature Therapeutics, Inc.. Retrieved from https://idiyas.com/company/signature-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…